NCT06287203 (ARFP) is a NA clinical trial of Addiction Risk Feedback Program in Substance Use, sponsored by Rutgers, The State University of New Jersey.

Who is sponsoring NCT06287203?

NCT06287203 is sponsored by Rutgers, The State University of New Jersey.

What drugs are being tested in NCT06287203?

Interventions in NCT06287203: Addiction Risk Feedback Program.

What condition does NCT06287203 study?

NCT06287203 studies Substance Use.

Is NCT06287203 still recruiting?

NCT06287203 is currently active, enrolled. Last updated 15 September 2025.

Last reviewed 2025-09-15 · How we verify

NCT06287203: ARFP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Novel Prevention Intervention Program to Reduce Risky Patterns of Substance Use Among Emerging Adults

Active, enrolled NA Last updated 15 September 2025

What this trial tests

NA trial testing Addiction Risk Feedback Program in Substance Use in 660 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

12 April 2024

Primary endpoint
31 January 2026

31 January 2026

Quick facts

Lead sponsor	Rutgers, The State University of New Jersey
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	660
Start date	12 April 2024
Primary completion	31 January 2026
Estimated completion	31 January 2026
Sites	1 location across United States

Drugs / interventions tested

Addiction Risk Feedback Program

Conditions studied

Substance Use — all drugs for Substance Use →

Sponsor

Rutgers, The State University of New Jersey

Who can join

Adults 18 to 25, any sex, with Substance Use. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to test whether completion of a new personalized feedback program is associated with reductions in risky substance use among emerging adults (18-25 years of age).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development of the Comprehensive Addiction Risk Evaluation System: Initial Participant Response to an Online Personalized Feedback Program Integrating Genomic, Behavioral, and Environmental Risk Information.
Dick DM, Choi M, Balcke E, Aliev F, et al · · 2025 · cited 2× · PMID 40988992 · DOI 10.1159/000547783

Verify or expand the search:

Other recruiting trials for Substance Use

Currently open trials in the same condition.

NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
NCT07509853 — Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engag · NA · recruiting
NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
NCT07512869 — Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Impl · recruiting

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

NCT07243886 — Mobile-based Obstetric Monitoring for Pregnancies Complicated by Hypertension and/or Diabetes (MOM-HD) · NA · not yet recruiting
NCT06955130 — Lactate and Glycerol Contribution to Gluconeogenesis · NA · not yet recruiting
NCT06822010 — SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma · Phase 2 · not yet recruiting
NCT07525011 — Comparative Study of Denture Fabrication Techniques · NA · not yet recruiting
NCT06834204 — Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06287203 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rutgers, The State University of New Jersey
Last refreshed: 15 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06287203.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing